Janssen Presents Updated Data Demonstrating Improved Outcomes from the Use of Niraparib in Combination with Abiraterone Acetate Plus Prednisone as a First-Line Therapy in Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer
SAN FRANCISCO, February 16, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated results from the Phase 3 MAGNITUDE study evaluating the investigational use of niraparib, a highly selective poly (ADP-ribose) polymerase (PARP) inhibitor, in combination with abiraterone acetate plus prednisone (AAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) with or without specific homologous recombination repair (HRR) gene alterations, including BRCA mutations. Results will be featured today in a Rapid Abstract Session (Abstract #170) at the American Society of Clinica...
Source: Johnson and Johnson - February 16, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Incidence of Pancreatic Cancer Increasing in Younger Women
TUESDAY, Feb. 14, 2023 -- Pancreatic cancer (PC) incidence is increasing among younger women, according to a study published online Feb. 10 in Gastroenterology.
Yazan Abboud, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues used... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 14, 2023 Category: Pharmaceuticals Source Type: news
Pancreatic Cancer Rates Rising Faster Among Women
Rates of pancreatic cancer are climbing the fastest among young women, particularly those who are Black. (Source: WebMD Health)
Source: WebMD Health - February 14, 2023 Category: Consumer Health News Source Type: news
Pancreatic Cancer Rates Rising Faster Among Women
TUESDAY, Feb. 14, 2023 -- While rates of pancreatic cancer are increasing for both men and women, they ’re climbing the fastest among young women, particularly those who are Black.
“We can tell that the rate of pancreatic cancer among women is... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 14, 2023 Category: General Medicine Source Type: news
The Five-Year Survival Rate for Pancreatic Cancer Is Increasing The Five-Year Survival Rate for Pancreatic Cancer Is Increasing
Lynn Matrisian, PhD, MBA, Chief Science Officer of the Pancreatic Cancer Action Network (PanCAN), shares her insights on the steady increase in the five-year survival rate for pancreatic cancer as well as her hope for the future.WebMD (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - February 13, 2023 Category: Surgery Tags: Hematology-Oncology Expert Interview Source Type: news
Pancreatic cancer rates rising fastest among young women, study finds - symptoms to spot
A study carried out in the US found survival rates for pancreatic cancer among men were improving but not among women. (Source: Daily Express - Health)
Source: Daily Express - Health - February 12, 2023 Category: Consumer Health News Source Type: news
Pruritus could be an 'early' sign of pancreatic cancer - it affects 75% of patients
Although you might brush pruritus away, it "should not be overlooked", according to a doctor. (Source: Daily Express - Health)
Source: Daily Express - Health - February 12, 2023 Category: Consumer Health News Source Type: news
Highlights From ASCO GI 2023 Highlights From ASCO GI 2023
Treatment advances presented at ASCO GI 2023 include a novel monoclonal antibody for gastric cancer, combination therapy for esophageal and pancreatic cancer, and molecular profiling for colon cancer.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 7, 2023 Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news
Faking a Cancer Dx? Fallopian Tube Removal; Trodelvy's New Breast Cancer Indication
(MedPage Today) -- A 19-year-old Iowa woman has been arrested after being accused of faking diagnoses of leukemia and pancreatic cancer in order to collect more than $37,000 in online donations. (CBS News)
The Ovarian Cancer Research Alliance... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 3, 2023 Category: Hematology Source Type: news
Retired New Jersey Doctor Admits to Fabricating Documents and Faking Diagnosis to Avoid Trial
FDA OCI, William Merlino, Mays Landing, NJ, plea, guilty, obstruction, justice, false, medical records, doctor ’s, letters, felony, misbranding, selling, toxic, chemical, weight-loss, drug, online, fake, diagnosis, pancreatic, cancer, DNP, health care fraud, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - February 2, 2023 Category: Medical Law Authors: DOJ Source Type: news
Will Steffen fought passionately for our planet. To honour him we must follow his lead | Penny Sackett
I am filled with grief at losing my friend at a time when we need his calm, direct voice more than everThis week science lost one of its greatest Earth system experts, Australia lost a skilled, passionate communicator of climate science and the world lost a humble soul of the highest humanity, kindness and integrity. As did scores of others, I lost a colleague and friend when Will Steffen left us on Sunday after a battle with pancreatic cancer.It is impossible to overstate Will ’s impact on science. The many tributes to his work can only scratch the surface of his legacy. He led the effort to map the Great Acceleration o...
Source: Guardian Unlimited Science - February 1, 2023 Category: Science Authors: Penny Sackett Tags: Climate crisis Australia news Environment Climate science Source Type: news
Mayo Clinic to lead new radiotracer trial for detecting pancreatic cancer
ROCHESTER, Minn. — In an academic-industrial collaboration, Mayo Clinic is assessing in a clinical trial a new radiotracer in pancreatic cancer imaging. As part of the investigation, the new agent, 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 (68Ga-FAPI-46), will be compared with 18-fluorodeoxyglucose ( FDG), which is the current standard-of-care radiotracer, in positron emission tomography (PET) imaging of pancreatic cancer. "The research will focus on pancreatic cancer and evaluate whether this radiotracer does what it's supposed to do, and whether it… (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - January 30, 2023 Category: Research Source Type: news
Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
This study, led by researchers at the Johns Hopkins Kimmel Cancer Center, is the latest from an ongoing platform trial formed in 2015 to study immunotherapy treatments before surgery (neoadjuvant) and after surgery (adjuvant) in patients with pancreatic cancer. (Source: World Pharma News)
Source: World Pharma News - January 27, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
New'Reference Regimen' in Metastatic Pancreatic Cancer? New'Reference Regimen' in Metastatic Pancreatic Cancer?
Liposomal irinotecan plus chemo in the new NALIRIFOX regimen significantly improved overall survival compared with standard therapy in metastatic pancreatic ductal adenocarcinoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 23, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
New First-Line Standard for Metastatic Pancreatic Cancer
(MedPage Today) -- SAN FRANCISCO -- A four-drug chemotherapy combination coaxed a statistically significant 2-month improvement in overall survival (OS) in untreated metastatic pancreatic cancer versus a gemcitabine-containing regimen, a large... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 22, 2023 Category: Gastroenterology Source Type: news
